SANUWAVE Health, Inc.

SNWV

SANUWAVE Health, Inc.

SNWV

Insider Sentiment (TTM):

Last Purchase:2025-10-06Last Sale:2026-05-01Shares Purchased (TTM):1,267Shares Sold (TTM):58,893

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:4,194,069Shares Outstanding:8,591,098Institutional Ownership Pct.:48.82%

Earnings Market Reaction:

Filing Date:2026-08-06Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Nonrelated Party	-	-	-	-	-	-	0	1	4	-	5	-
Related Party	-	-	-	-	-	-	0	1	4	-	5	-
Assets Current
Cash And Cash Equivalents At Carrying Value	9	11	12	10	8	9	10	3	2	3	2	1
Accounts Receivable Net Current	6	6	5	5	4	4	3	3	3	3	3	3
Inventory Net	7	6	6	7	6	5	4	3	3	2	3	2
Prepaid Expense And Other Assets Current	1	1	1	2	2	1	1	0	0	2	2	1
Assets Current	23	24	25	23	20	19	18	10	9	11	10	7
Assets Noncurrent
Property Plant And Equipment Net	2	2	2	2	2	0	0	1	1	1	1	1
Operating Lease Right Of Use Asset	1	1	0	0	1	0	0	-	-	-	-	-
Intangible Assets Net Excluding Goodwill	3	3	3	3	3	4	4	4	4	4	4	5
Goodwill	7	7	7	7	7	7	7	7	7	7	7	7
Deferred Finance Costs Noncurrent Net	-	0	0	0	-	-	0	-	-	-	-	-
Assets Noncurrent	13	13	13	13	13	12	12	12	12	12	13	13
Assets	37	37	37	36	33	31	30	22	21	23	22	20
Liabilities
Liabilities Current
Convertible Notes Payable Current	-	-	-	-	-	-	-	8	6	-	7	-
Other Notes Payable	-	-	-	-	-	-	-	1	1	-	-	-
Secured Debt Current	6	6	6	6	-	-	0	-	-	-	-	-
Senior Notes Current	-	-	0	0	27	26	25	24	23	19	18	18
Accounts Payable Current	3	3	3	4	4	4	4	4	4	5	6	5
Accrued Liabilities Current	9	9	8	4	3	4	8	5	5	7	6	6
Operating Lease Liability Current	0	0	0	0	0	0	0	-	-	-	-	-
Finance Lease Liability Current	-	-	0	0	0	-	0	-	-	-	-	-
Contract With Customer Liability Current	1	0	0	0	0	0	0	0	0	0	0	0
Interest Payable Current	0	0	0	-	-	-	0	-	-	-	5	-
Other Liabilities Current	0	0	0	0	0	0	0	0	0	1	1	1
Liabilities Current	18	18	18	20	47	47	45	82	60	70	65	85
Liabilities Noncurrent
Deferred Income Tax Liabilities Net	-	-	-	-	-	-	-	-	-	-	-	0
Secured Long Term Debt	13	14	16	17	-	-	0	-	-	-	-	-
Line Of Credit	1	1	1	1	-	-	0	-	-	-	-	-
Finance Lease Liability Noncurrent	-	-	0	0	0	-	0	-	-	-	-	-
Contract With Customer Liability Noncurrent	1	1	1	0	0	0	0	0	0	0	0	0
Other Liabilities Noncurrent	-	-	-	-	0	-	-	-	-	-	-	-
Liabilities Noncurrent	16	17	18	19	1	1	0	1	1	1	1	1
Liabilities	34	35	36	39	48	48	46	82	61	71	66	86
Preferred Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Value	0	0	0	0	0	0	0	0	1	1	0	1
Additional Paid In Capital	248	246	244	243	241	240	239	178	177	176	177	171
Retained Earnings Accumulated Deficit	-245	-244	-243	-246	-256	-257	-254	-239	-218	-225	-220	-238
Accumulated Other Comprehensive Income Loss Net Of…	0	0	0	0	0	0	0	0	0	0	-0	-0
Stockholders Equity	3	2	2	-3	-19	-21	-16	-60	-40	-48	-43	-66
Liabilities And Stockholders Equity	37	37	37	36	33	31	30	22	21	23	22	20
Series A Preferred Stock	-	0	0	0	0	0	0	0	0	-	0	-
Series B Preferred Stock	-	0	0	0	0	0	0	0	0	-	0	-
Series C Preferred Stock	-	0	0	0	0	0	0	0	0	-	0	-
Series D Preferred Stock	-	0	0	0	0	0	0	0	0	-	0	-
Subsequent Event	-	-	-	-	-	-	-	5	-	-	-	-
Allowance For Doubtful Accounts Receivable Current	2	1	1	1	1	1	1	1	1	1	1	1
Stockholders Equity
Preferred Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Preferred Stock Shares Authorized	5	5	5	5	5	5	5	5	5	5	5	5
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Common Stock Shares Authorized	2,500	2,500	2,500	2,500	2,500	2,500	2,500	2,500	2,500	2,500	2,500	2,500
Common Stock Shares Issued	9	9	9	9	9	9	9	3	1,181	1,141	3	1,026
Shares Outstanding	9	9	9	9	9	9	9	3	1,181	1,141	3	1,026

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-7.98%	-33.73%	-61.53%	-	-	-	-	-	-	-	-	-
2025	-16.96%	-5.07%	20.00%	21.33%	0.23%	-9.76%	28.44%	15.45%	0.68%	9.34%	-10.61%	-20.90%
2024	-	-	-	-	-	-	8.25%	18.30%	45.31%	-6.50%	-5.94%	-12.78%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	1.28	1.31	1.38	1.16	0.43	0.40	0.41	0.12	0.15	0.15	0.15	0.09
Quick Ratio	0.84	0.92	0.97	0.73	0.27	0.26	0.30	0.07	0.09	0.08	0.08	0.05
Working Capital	5.03M	5.65M	6.78M	3.06M	-26.33M	-28.44M	-27.03M	-71.61M	-51.24M	-59.35M	-54.97M	-78.04M
Leverage & Debt
Debt to Equity	12.13	19.18	22.07	-13.15	-2.54	-2.31	-2.91	-1.36	-1.53	-1.49	-1.52	-1.31
Interest Coverage TTM	0.43	0.66	0.79	0.54	0.51	0.49	0.31	0.31	0.12	0.03	-0.04	-0.23
Debt Ratio	0.92	0.95	0.96	1.08	1.45	1.56	1.52	3.76	2.88	3.04	2.93	4.24
Efficiency & Turnover
Asset Turnover TTM	1.26	1.30	1.31	1.43	1.45	1.34	1.24	1.39	1.24	1.10	0.96	0.93
Days Sales Outstanding TTM	40.00	40.61	36.25	33.06	32.70	34.67	37.15	37.79	43.78	48.68	65.70	54.40
Receivables Turnover TTM	9.12	8.99	10.07	11.04	11.16	10.53	9.83	9.66	8.34	7.50	5.56	6.71
Per Share Metrics
Diluted EPS TTM	1.77	1.92	1.30	-1.06	-4.44	-4.06	-7.41	-0.12	-0.93	-5.57	-12.19	-20.89
Free Cash Flow Per Share TTM	0.49	0.46	0.23	-0.09	-0.01	-0.08	0.44	0.00	-1.04	-1.13	-2.30	-3.11
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	76.33%	76.74%	77.11%	78.20%	77.63%	76.62%	75.23%	72.84%	71.57%	71.63%	70.41%	73.20%
Operating Profit Margin TTM	3.41%	7.26%	11.23%	10.83%	12.66%	15.20%	11.79%	13.42%	5.82%	1.73%	-2.65%	-16.09%
Net Profit Margin TTM	34.66%	37.20%	26.82%	-23.57%	-104.12%	-95.83%	-101.38%	-1.33%	-13.79%	-77.00%	-126.52%	-263.14%
Growth Metrics
Net Revenue Growth (1Y)	12.67%	22.54%	34.98%	40.48%	56.94%	61.46%	59.99%	55.03%	37.43%	29.37%	21.84%	21.92%
Net Income Growth (1Y)	-137.51%	-147.56%	-135.71%	2,393.83%	1,085.40%	100.94%	28.19%	-99.22%	-87.37%	-5.57%	150.72%	253.99%
EPS Growth (1Y)	-137.33%	-147.32%	-118.61%	826.84%	336.49%	-27.14%	-39.19%	-99.42%	2,232.54%	17,420.64%	64,977.73%	83,315.58%
Valuation Metrics
P/E TTM	5.64	9.01	21.63	-33.11	-6.92	-8.72	-3.10	-	-	-	-	-
P/B TTM	30.86	80.82	157.84	-109.60	-14.97	-14.53	-6.50	-	-	-	-	-
P/S TTM	1.95	3.35	5.80	7.80	7.20	8.36	3.15	-	-	-	-	-
Market Cap	86.01M	148.54M	255.54M	321.25M	281.34M	302.33M	102.65M	-	-	-	-	-
Enterprise Value	95.16M	157.68M	264.88M	334.35M	272.97M	293.83M	101.31M	-	-	-	-	-
Calculated Values
Free Cash Flow TTM	4.24M	3.99M	1.93M	-784.00K	-106.00K	-700.00K	1.97M	6.00K	-3.27M	-3.50M	-4.88M	-7.42M
Net Debt	9.15M	9.14M	9.35M	13.11M	-8.37M	-8.50M	-1.34M	4.40M	3.95M	-2.94M	5.31M	-1.10M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-05-01Sale

Owner: Opaleye, Management Inc.

Title: -

Shares: 10,581

Price/Share: $16.11

Value: $170,459.91

Shares Owned: 5,000

Relationship: TenPercentOwner

Ownership: Indirect

2026-04-29Sale

Owner: Opaleye, Management Inc.

Title: -

Shares: 24,360

Price/Share: $17.25

Value: $420,210.00

Shares Owned: 6,500

Relationship: TenPercentOwner

Ownership: Indirect

2026-04-21Sale

Owner: Opaleye, Management Inc.

Title: -

Shares: 202

Price/Share: $20.50

Value: $4,141.00

Shares Owned: 954,798

Relationship: TenPercentOwner

Ownership: Indirect

2025-12-12Sale

Owner: Manchester, Management Pr…

Title: -

Shares: 6,500

Price/Share: $21.04

Value: $136,760.00

Shares Owned: 63,999

Relationship: Other

Ownership: Indirect

2025-12-10Sale

Owner: Besser, James E, Manchest…

Title: -

Shares: 8,625

Price/Share: $30.39

Value: $262,113.75

Shares Owned: 863,980

Relationship: Other

Ownership: Indirect

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-05-01	Opaleye, Management Inc.	TenPercentOwner	-	Indirect	Sale	10,581	16.11	$170,459.91	5,000	4
2026-04-29	Opaleye, Management Inc.	TenPercentOwner	-	Indirect	Sale	24,360	17.25	$420,210.00	6,500	4
2026-04-21	Opaleye, Management Inc.	TenPercentOwner	-	Indirect	Sale	202	20.50	$4,141.00	954,798	4
2025-12-12	Manchester, Management Pr…	Other	-	Indirect	Sale	6,500	21.04	$136,760.00	63,999	4
2025-12-10	Besser, James E, Manchest…	Other	-	Indirect	Sale	8,625	30.39	$262,113.75	863,980	4/A
2025-12-10	Manchester, Management Co…	Other	-	Indirect	Sale	8,625	30.39	$262,113.75	863,980	4
2025-10-06	Opaleye, Management Inc.	TenPercentOwner	-	Indirect	Purchase	1,267	30.28	$38,364.76	966,267	4
2025-06-05	Stegagno, Peter	Officer	Chief Operating Officer	Direct	Sale	1,862	27.71	$51,596.02	2,032	4
2025-05-15	Cioanta, Iulian	Officer	Chief Sci. and Tech. Officer	Direct	Sale	3,639	31.60	$114,992.40	41	4
2025-04-29	Opaleye, Management Inc.	TenPercentOwner	-	Indirect	Purchase	7,998	25.49	$203,869.02	965,000	4
2024-11-01	Opaleye, Management Inc.	TenPercentOwner	-	Indirect	Purchase	16,000	15.20	$243,200.00	960,000	4
2024-10-18	Manchester, Management Co…	Other	-	Indirect	Purchase	181,818	8.25	$1,499,998.50	1,006,790	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

48.82%

Inst. Shares: 4,194,069

Shares Outstanding: 8,591,098

2025-12-31

45.13%

Inst. Shares: 3,864,896

Shares Outstanding: 8,563,510

2025-09-30

39.37%

Inst. Shares: 3,374,199

Shares Outstanding: 8,571,111

2025-06-30

36.78%

Inst. Shares: 3,149,002

Shares Outstanding: 8,561,737

2025-03-31

29.06%

Inst. Shares: 2,484,259

Shares Outstanding: 8,547,675

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	4,194,069	8,591,098	48.82%
2025-12-31	3,864,896	8,563,510	45.13%
2025-09-30	3,374,199	8,571,111	39.37%
2025-06-30	3,149,002	8,561,737	36.78%
2025-03-31	2,484,259	8,547,675	29.06%
2024-12-31	1,333	4,462,883	0.03%
2024-09-30	500,000	3,185,495	15.70%
2024-06-30	500,000	3,152,595	15.86%
2023-12-31	500,000	2,116,936	23.62%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

SANUWAVE Health, Inc. (SNWV) — SEC Financial Statements & Analysis

SANUWAVE Health, Inc. (SNWV) is a surgical & medical instruments & apparatus company, incorporated in NV. SANUWAVE Health, Inc. trades on Nasdaq as: SNWV. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), SANUWAVE Health, Inc. reported a 12.67% year-over-year revenue growth, a Gross Profit Margin of 76.33% (TTM), a Debt-to-Equity ratio of 12.13x, a Price-to-Sales (P/S) ratio of 1.95x (TTM), a Price-to-Book (P/B) ratio of 30.86x (TTM), at a market cap of $86.01M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 12.67%
Gross Profit Margin TTM: 76.33%
Debt To Equity: 12.13x
P/S TTM: 1.95x
P/B TTM: 30.86x
Market Cap: $86.01M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is SANUWAVE Health, Inc. in?

SANUWAVE Health, Inc. (SNWV) operates in the Surgical & Medical Instruments & Apparatus industry.

What is SNWV's market cap?

SANUWAVE Health, Inc. (SNWV) has a market capitalization of $86.01M as of 2026-06-30.

What is SNWV's P/E ratio?

SANUWAVE Health, Inc. (SNWV)'s trailing twelve month P/E ratio is 5.64x as of 2026-06-30.

What exchange does SNWV trade on?

SANUWAVE Health, Inc. (SNWV) trades on the Nasdaq.

Where is SANUWAVE Health, Inc. incorporated?

SANUWAVE Health, Inc. is incorporated in NV.